Treatment

Finerenone clinical trials

Active studies that list Finerenone as an intervention or treatment.

4active studies

2recruiting now

6countries represented

4largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 4

Chronic Kidney Disease(CKD)Condition

Dapagliflozin, SemaglutideTreatment

Denmark, Germany4 locations

Peter RossingSponsor

Updated 2025-11-20 · NCT07239570See eligibility →

Recruiting nowPhase 3

Cardiovascular Diseases, Heart FailureCondition

Aspirin tablet, SemaglutideTreatment

Denmark2 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-01-10 · NCT06082063See eligibility →

Opening soonPhase 4

Type 2 Diabetic Kidney DiseaseCondition

empagliflozin, FinerenoneTreatment

China1 locations

Huijie ZhangSponsor

Updated 2026-08-20 · NCT07775846See eligibility →

Opening soonPhase 4

Chronic Kidney Disease, Type 2 DiabetesCondition

Finerenone, SemaglutideTreatment

United States1 locations

Baylor Research InstituteSponsor

Updated 2026-05-08 · NCT07547878See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.